The Denmark data were from population-based health registries that included all women diagnosed during 1999–2011 with regional or stage II/III breast cancer and showed predictors of recurrence, metastases, and mortality, including age, hormone receptor status, and stage at diagnosis [28]. Here, NR4A1 is linked to breast carcinoma.